June 24, 2019 Price forecast | 2 weeks: -0.40% | 1 month: -0.81% | 3 months: 1.91%

NERV stock forecast

Our latest prediction for Minerva Neurosciences, Inc.'s stock price was made on the June 24, 2019 when the stock price was at 5.93$.

In the short term (2weeks), NERV's stock price should underperform the market by -0.40%. During that period the price should oscillate between -11.89% and +18.19%.

In the medium term (3months), NERV's stock price should outperform the market by 1.91%. During that period the price should oscillate between -22.52% and +36.80%.

Create a solid portfolio with NERV

Add NERV to your portfolio and optimize it!

About Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-117, and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.75$ per share.

The book value per share is 2.85$

Minerva Neurosciences, Inc. website

Three months stock forecastJune 24, 2019


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -72M - -69M -1.75 - - 39M 2.85 -43M - -43M